Indivior Pharmaceuticals Inc logo INDV - Indivior Pharmaceuticals Inc

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 3
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $44.67 DETAILS
HIGH: $50.00
LOW: $36.00
MEDIAN: $48.00
CONSENSUS: $44.67
UPSIDE: 19.02%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4
Revenue
Revenue 317.0 358 314 302 266 299 307 299 284 293 271 276 253 242 232 221 207 223
Cost of Revenue 40.0 64 62 52 44 23 69 79 38 51 46 50 39 44 40 38 37 39
Gross Profit 277.0 294 252 250 222 276 238 220 246 242 225 226 214 198 192 183 170 184
Operating Expenses
R&D Expenses 16 17 20 21 22 31 22 26 28 29 18 32 27 29 20 14 8 19
SG&A Expenses 124 155 133 158 132 (47) 208 152 144 157 390 133 131 432 115 109 109 136
Other Expenses 0 0 0 (1) 2 196 4 160 (1) (5) 0 0 (1) (5) 1 (3) (1) (16)
Operating Expenses 140 172 153 178 156 180 234 338 171 181 408 165 157 456 136 120 116 139
Operating Income
Operating Income 137 122 99 72 66 96 4 (118) 75 61 (183) 61 57 (258) 56 63 54 45
Interest Expense 7.0 6 12 15 12 13 10 9 8 9 10 10 10 8 8 7 6 7
Interest Income 3.0 6 6 6 4 5 5 6 6 10 12 11 11 11 6 2 0 1
Profitability
EBITDA 139.0 127 104 82 76 106 22 (106) 87 79 (164) 78 74 (243) 68 71 59 50
EBIT 137 122 99 77 71 101 9 (112) 82 70 (171) 72 68 (247) 62 65 54 46
Income Before Tax 115 81 37 62 59 88 (1) (121) 73 62 (181) 62 58 (255) 54 58 48 40
Income Tax Expense 26.0 (21) (5) 44 11 28 (5) (23) 11 8 (46) 23 14 (72) 13 10 7 4
Net Income 89.0 102 42 18 47 59 4 (97) 61 54 (135) 39 44 (183) 41 48 41 36
Per Share Data
EPS (Basic) 0.71 0.82 0.34 0.14 0.38 0.45 0.03 -0.72 0.45 0.39 -0.94 0.29 0.33 -1.38 0.28 0.33 0.29 0.25
EPS (Diluted) 0.69 0.82 0.33 0.14 0.38 0.45 0.03 -0.72 0.45 0.38 -0.94 0.28 0.32 -1.38 0.27 0.33 0.27 0.25
Shares Outstanding 125.4 125 125 123.7 123.7 126.6 132.1 134.8 135.7 137.3 137.7 138.1 136.5 136.5 137.8 139.7 140.7 140.5
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4
Current Assets
Cash & Cash Equivalents 175 195 445 510 372 319 288 302.0 247.8 316 610 592 588 778.2 821 858.9 874 1,102
Short-Term Investments 0 0 0 0 1 1 30 77.0 81.9 94 112 97 117 119.6 97 77.2 65 0
Net Receivables 285 255 272 240 243 254 251 259 249 254 261 240 246 220 215 196 208 215
Inventory 152 153 157 149 163 178 178 171.0 162.9 135 142 131 123 114.6 106 100.2 91 95
Other Current Assets 55 15 18 24 48 87 34 37.0 22.8 444 67 13 22 18 10 101 10 14
Total Current Assets 667 652 922 951 883 839 799 864.1 795.4 1,266 1,220 1,094 1,122 1,265.8 1,264 1,343.9 1,263 1,444
Non-Current Assets
Property, Plant & Equipment 179 170 154 152 141 139 116 107.0 111.9 124 85 89 88 85.5 80 86.2 90 95
Goodwill 0 0 0 0 0 2 2 2.0 2.0 0 0 0 0 0.4 0 0 0 0
Intangible Assets 2 2 2 7 7 5 188 216 228 13 218 199 200 70 67 73.2 78 82
Long-Term Investments 27 28 28 27 27 26 26 26.0 26.0 41 52 93 98 98.5 117 81.2 85 0
Other Non-Current Assets 26 26 27 44 38 29 29 30.0 28.8 28 25 46 46 38.2 37 38.1 105 106
Total Non-Current Assets 530 552 496 500 492 481 665 671.1 656.5 499 632 637 633 512.8 407 379.8 461 388
Total Assets 1,197 1,204 1,416 1,452 1,375 1,319 1,464 1,535.2 1,451.9 1,765 1,852 1,731 1,755 1,778.6 1,671 1,723.8 1,724 1,832
Current Liabilities
Account Payables 178 48 41 50 183 63 50 46 40 39 71 53 36 33 76 107 518 573
Short-Term Debt 0 39 18 18 18 18 3 3 3 12 11 12 11 3 10 3 11 11
Deferred Revenue 0 0 0 0 0 0 0 8.0 7.0 0 0 0 0 9.0 0 5.0 0 0
Other Current Liabilities 566 722 78 934 (31) 802 826 174.2 80.4 1,159 1,152 902 989 391 639 530 188 213
Total Current Liabilities 779 914 965 1,056 1,005 939 962 1,012.2 860.4 1,290 1,239 972 1,043 1,024.5 744 788.7 728 804
Non-Current Liabilities
Long-Term Debt 486 290 304 308 311 315 235 235 234.8 237 236 236 236 237 237 237 238 239
Deferred Tax Liabilities 0 3 0 0 0 0 0 0 0 5 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 62 73 330 317 315 381 399 376 314.8 390 371 373 372 436.8 434 434 493 550
Total Non-Current Liabilities 562 388 658 654 656 728 669 644.1 581.6 666 637 642 640 702.8 700 704.5 764 825
Total Liabilities 1,341 1,302 1,623 1,710 1,661 1,667 1,631 1,656.3 1,441.9 1,956 1,876 1,614 1,683 1,727.3 1,444 1,493.3 1,492 1,629
Stockholders' Equity
Common Stock 0 62 62 62 62 62 65 67.0 67.9 68 69 69 69 68.4 69 70.2 71 70
Retained Earnings (280) (243) (346) (388) (406) (454) 1,070 1,124.2 1,255.1 (295) 1,233 1,363 1,322 1,310.0 1,496 1,487.2 1,472 1,438
Accumulated Other Comprehensive Income (29) (30) (32) (33) (35) (46) 0 (1,323.2) (1,324.0) (1,348) (1,337) (1,324) (1,328) (1,335.2) (1,346) (1,333.9) (1,318) (1,312)
Total Stockholders' Equity (144) (98) (207) (258) (286) (348) (167) (121.0) 10.0 (191) (24) 117 72 51.3 227 230.5 232 203
Total Liabilities & Equity 1,197 1,204 1,416 1,452 1,375 1,319 1,464 1,535.2 1,451.9 1,765 1,852 1,731 1,755 1,778.6 1,671 1,723.8 1,724 1,832
Debt Metrics
Total Debt 509 351 356 366 370 375 284 281.0 278.8 283 277 281 279 277 276 280.6 282 286
Net Debt 334 156 (89) (144) (2) 56 (4) (21.0) 31.0 (33) (333) (311) (309) (501.2) (545) (578.3) (592) (816)
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4
Operating Activities
Net Income 89 102 43 18 47 20 3 (107.2) 46.8 54 (135) 39 57 (183) 41 48 54 35
Depreciation & Amortization 4 5 5 5 5 0 (10) 6 9.0 9 7 6 6 4 6 6 5 4
Stock-Based Compensation 0 5 7 8 6 0 7 5 5 0 0 0 5 0 0 0 3 0
Change in Working Capital (163) (302.5) (97) 126.2 17 (125.6) (41) 190 (80.6) (366.6) 211.4 (87.2) (62) 232.8 15.9 (14.7) (115) 139.6
Other Non-Cash Items 34 5.5 18 9.6 0 94.0 49 (6.0) (34.9) 23.9 (62.2) 22.4 (42) (70.7) (3.4) (10.8) (22) (18.3)
Operating Cash Flow (9) (221) (39) 166.0 75 (5.6) 8 87.8 (54.8) (279.7) 21.2 (19.8) (36) (16.9) 59.5 28.6 (75) 160.3
Investing Activities
Capital Expenditure (20) (24) (20) (17.7) (5) (15.8) (9) (4.0) (2.0) (3.9) (2.0) (1.0) (6) (1.0) (1.8) (1.9) 0 (1.9)
Acquisitions 0 0 0 0 0 0 0 0 0 (2.3) (0.5) (1.9) (124) 0 0 0 0 0
Purchases of Investments (5) (6) (3) (6.3) (5) (2.8) (5) (5.0) (4.0) (4.1) (4.2) (3.5) (33) (16.0) (51.8) (15.5) (150) 0
Sales/Maturities of Investments 6 6 3 5.3 6 27.7 47.9 10.9 30.9 31.9 31.9 29.0 36 11.7 4.3 9.7 0 0
Other Investing Activities 0 0 0 1 (1) 0 (3.9) (0.9) 0 0 0 0 (5) 0.0 (0.0) (0.0) 1 (0.4)
Investing Cash Flow (19) (24) (20) (18.7) (5) 9.1 32 1 24.9 8.2 (1.5) 22.4 (127) (6.2) (49.4) (7.8) (149) (1.7)
Financing Activities
Net Debt Issuance 151 (4.8) (4) (4.2) (4) 2.0 (1) 0 (3) 12.2 (1.1) (0.2) (11) 1.9 (1.9) 0.0 (1) (0.3)
Stock Repurchased (126) 0.2 0 (0.3) (11) (49.3) (52) (34) (35.8) (21.7) (0.0) (0.2) (11) (24.1) (33.5) (28.1) 0 (65.0)
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (18) (0.3) (1) (0.1) (3) 75.3 (3) (0.8) 1.2 (10.8) (2.1) (2.1) (2) (5.8) (0.8) (1.9) (2) (1.9)
Financing Cash Flow 7 (5) (3) (4.6) (17) 29.1 (55) (34.8) (37.8) (20.4) (1.1) (2.4) (22) (28.1) (34.3) (30.9) (2) (66.2)
Cash Position
Net Change in Cash (20) (250) (65) 138 53 31 (14) 54.2 (67.7) (294) 18 4 (186) (47) (36) (17) (228) 97
Cash at Beginning 195 445 510 372 319 288 302 247.8 315.6 610 592 588 774 821 857 874 1,102 1,005
Cash at End 175 195 445 510 372 319 288 302.0 247.8 316 610 592 588 774 821 857 874 1,102
Free Cash Flow (29) (245) (59) 148.4 70 (21.5) (1) 83.8 (56.7) (283.6) 19.1 (20.9) (42) (17.9) 57.7 26.6 (75) 158.4
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4
Income Statement
Revenue 317.0 358 314 302 266 299 307 299 284 293 271 276 253 242 232 221 207 223
Gross Profit 277.0 294 252 250 222 276 238 220 246 242 225 226 214 198 192 183 170 184
Operating Income 137 122 99 72 66 96 4 (118) 75 61 (183) 61 57 (258) 56 63 54 45
Net Income 89.0 102 42 18 47 59 4 (97) 61 54 (135) 39 44 (183) 41 48 41 36
EPS (Diluted) 0.69 0.82 0.33 0.14 0.38 0.45 0.03 -0.72 0.45 0.38 -0.94 0.28 0.32 -1.38 0.27 0.33 0.27 0.25
Balance Sheet
Cash & Equivalents 175 195 445 510 372 319 288 302.0 247.8 316 610 592 588 778.2 821 858.9 874 1,102
Total Assets 1,197 1,204 1,416 1,452 1,375 1,319 1,464 1,535.2 1,451.9 1,765 1,852 1,731 1,755 1,778.6 1,671 1,723.8 1,724 1,832
Total Debt 509 351 356 366 370 375 284 281.0 278.8 283 277 281 279 277 276 280.6 282 286
Stockholders' Equity (144) (98) (207) (258) (286) (348) (167) (121.0) 10.0 (191) (24) 117 72 51.3 227 230.5 232 203
Cash Flow
Operating Cash Flow (9) (221) (39) 166.0 75 (5.6) 8 87.8 (54.8) (279.7) 21.2 (19.8) (36) (16.9) 59.5 28.6 (75) 160.3
Capital Expenditure (20) (24) (20) (17.7) (5) (15.8) (9) (4.0) (2.0) (3.9) (2.0) (1.0) (6) (1.0) (1.8) (1.9) 0 (1.9)
Free Cash Flow (29) (245) (59) 148.4 70 (21.5) (1) 83.8 (56.7) (283.6) 19.1 (20.9) (42) (17.9) 57.7 26.6 (75) 158.4